Don't miss the 2016 Cell & Gene Meeting on the Mesa - October 5-7, 2016. Join 800+ attendees for the sector's premier conference bringing together top decision makers in the field to advance cutting-edge research into cures.

ARM'S Q2 2016 QUARTERLY DATA REPORT DETAILS INDUSTRY-SPECIFIC STATISTICS COMPILED FROM MORE THAN 700 LEADING GENE THERAPY, CELL THERAPY AND OTHER REGENERATIVE MEDICINE COMPANIES WORLDWIDE. 

Learn more about ARM's Technology Sections - Cell Therapy, Gene & Gene-Modified Cell Therapy and Tissue Engineering & Biomaterials - created to ensure these major technology constituencies within ARM's membership are given a primary voice within the organization.

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

200+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more